Zoetis Inc. (ZTS): Price and Financial Metrics

ZTS POWR Grades

• Quality is the dimension where ZTS ranks best; there it ranks ahead of 95.14% of US stocks.
• The strongest trend for ZTS is in Value, which has been heading up over the past 26 weeks.
• ZTS ranks lowest in Momentum; there it ranks in the 8th percentile.

ZTS Stock Summary

• ZTS has a market capitalization of $71,332,318,835 -- more than approximately 97.06% of US stocks.
• With a one year PEG ratio of 593.89, ZOETIS INC is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 95.74% of US stocks.
• The price/operating cash flow metric for ZOETIS INC is higher than 88.2% of stocks in our set with a positive cash flow.
• Stocks that are quantitatively similar to ZTS, based on their financial statements, market capitalization, and price volatility, are SYK, BDX, ABB, ETN, and MDT.
• ZTS's SEC filings can be seen here. And to visit ZOETIS INC's official web site, go to www.zoetis.com.

ZTS Valuation Summary

• In comparison to the median Healthcare stock, ZTS's EV/EBIT ratio is 239.51% higher, now standing at 27.5.
• Over the past 120 months, ZTS's price/earnings ratio has gone down 28.3.

Below are key valuation metrics over time for ZTS.

ZTS Growth Metrics

The year over year net cashflow from operations growth rate now stands at 0.19%.
• Its 5 year cash and equivalents growth rate is now at 168.36%.
• Its 4 year net cashflow from operations growth rate is now at 154.42%.

ZTS's revenue has moved up $1,747,000,000 over the prior 33 months.

The table below shows ZTS's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	8,007	1,850	2,067
2022-06-30	7,995	1,977	2,090
2022-03-31	7,891	2,122	2,073
2021-12-31	7,776	2,213	2,037
2021-09-30	7,616	2,252	1,982
2021-06-30	7,412	2,161	1,909

ZTS's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• ZTS has a Quality Grade of A, ranking ahead of 95.14% of graded US stocks.
• ZTS's asset turnover comes in at 0.552 -- ranking 69th of 682 Pharmaceutical Products stocks.
• UTHR, ENDP, and MYGN are the stocks whose asset turnover ratios are most correlated with ZTS.

The table below shows ZTS's key quality metrics over time.